Polychemotherapy for early breast cancer: An overview of the randomized trials

Three to six months of adjuvant CT using CMF or anthracycline-containing regimens significantly reduces relapse and death in node-negative and node-positive breast cancer. Given the smaller absolute benefit in older women (2-3%) compared with younger women (7-11%), a decision to offer CT should always take potential side-effects into consideration.